Spatiotemporal changes of apolipoprotein E immunoreactivity and apolipoprotein E mRNA expression after transient middle cerebral artery occlusion in rat brain. 2003

Hiroshi Kamada, and Keiko Sato, and Wen Ri Zhang, and Nobuhiko Omori, and Isao Nagano, and Mikio Shoji, and Koji Abe
Department of Neurology, Graduate School of Medicine and Dentistry, Okayama University, Okayama, Japan. h_kamada@cc.okayama-u.ac.jp

Apolipoprotein E (ApoE) is a constituent of lipoprotein and plays an important role in the maintenance of neural networks. However, spatiotemporal differences in ApoE expression and its long-term role in neural process after brain ischemia have not been studied. We investigated changes of ApoE immunoreactivity and ApoE mRNA expression both in the core and in the periischemic area at 1, 7, 21, or 56 days after 90 min of transient middle cerebral artery occlusion. Double stainings for ApoE plus NeuN or plus ED1 were performed in order to identify cell type of ApoE-positive stainings. The maximal increase of ApoE expression was observed at 7 days in the core and at 7 and 21 days in the periischemic area. In the core, ApoE plus NeuN double-positive cells increased at 1 and 7 days, without ApoE mRNA expression, whereas they increased in the periischemic area, with a peak at 21 days, with ApoE mRNA expression in glial cells but not in neurons. On the other hand, ApoE plus ED1 double-positive cells increased only in the core, with a peak in number at 7 and 21 days and marked ApoE mRNA expression in macrophages. The present study suggests that ApoE plays various important roles in different type of cells, reflecting spatiotemporal dissociation between degenerative and regenerative processes after brain ischemia, and that ApoE is profoundly involved in pathological conditions, such as brain ischemia.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Hiroshi Kamada, and Keiko Sato, and Wen Ri Zhang, and Nobuhiko Omori, and Isao Nagano, and Mikio Shoji, and Koji Abe
January 2000, Brain research,
Hiroshi Kamada, and Keiko Sato, and Wen Ri Zhang, and Nobuhiko Omori, and Isao Nagano, and Mikio Shoji, and Koji Abe
October 2001, Neurological research,
Hiroshi Kamada, and Keiko Sato, and Wen Ri Zhang, and Nobuhiko Omori, and Isao Nagano, and Mikio Shoji, and Koji Abe
June 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
Hiroshi Kamada, and Keiko Sato, and Wen Ri Zhang, and Nobuhiko Omori, and Isao Nagano, and Mikio Shoji, and Koji Abe
March 2005, Brain research,
Hiroshi Kamada, and Keiko Sato, and Wen Ri Zhang, and Nobuhiko Omori, and Isao Nagano, and Mikio Shoji, and Koji Abe
January 1995, Journal of the neurological sciences,
Hiroshi Kamada, and Keiko Sato, and Wen Ri Zhang, and Nobuhiko Omori, and Isao Nagano, and Mikio Shoji, and Koji Abe
July 1998, Neurological research,
Hiroshi Kamada, and Keiko Sato, and Wen Ri Zhang, and Nobuhiko Omori, and Isao Nagano, and Mikio Shoji, and Koji Abe
June 2022, Neurology international,
Hiroshi Kamada, and Keiko Sato, and Wen Ri Zhang, and Nobuhiko Omori, and Isao Nagano, and Mikio Shoji, and Koji Abe
August 2000, Neuropathology and applied neurobiology,
Hiroshi Kamada, and Keiko Sato, and Wen Ri Zhang, and Nobuhiko Omori, and Isao Nagano, and Mikio Shoji, and Koji Abe
November 2002, Brain research,
Hiroshi Kamada, and Keiko Sato, and Wen Ri Zhang, and Nobuhiko Omori, and Isao Nagano, and Mikio Shoji, and Koji Abe
July 2001, Brain research,
Copied contents to your clipboard!